Raphael Mannino
2018
In 2018, Raphael Mannino earned a total compensation of $294.6K as Chief Scientific Officer at Matinas BioPharma Holdings, a 50% decrease compared to previous year.
Compensation breakdown
| Option Awards | $54,636 |
|---|---|
| Salary | $240,000 |
| Total | $294,636 |
Mannino received $240K in salary, accounting for 81% of the total pay in 2018.
Mannino also received $54.6K in option awards.
Rankings
In 2018, Raphael Mannino's compensation ranked 13,206th out of 14,244 executives tracked by ExecPay. In other words, Mannino earned more than 7.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 13,206 out of 14,244 | 7th |
Division Manufacturing | 5,353 out of 5,759 | 7th |
Major group Chemicals And Allied Products | 2,003 out of 2,122 | 6th |
Industry group Drugs | 1,718 out of 1,811 | 5th |
Industry Pharmaceutical Preparations | 1,313 out of 1,385 | 5th |
Source: SEC filing on September 24, 2019.
Mannino's colleagues
We found four more compensation records of executives who worked with Raphael Mannino at Matinas BioPharma Holdings in 2018.